Cargando…
Targeted cytotoxic analogue of bombesin/ gastrin-releasing peptide inhibits the growth of H-69 human small-cell lung carcinoma in nude mice
Recently, we developed a powerful cytotoxic analogue of bombesin AN-215, in which the bombesin-like carrier peptide Gln–Trp–Ala–Val–Gly–His–Leu–Ψ(CH(2)-NH)–Leu–NH(2) (RC-3094) is conjugated to a potent derivative of doxorubicin, 2-pyrrolinodoxorubicin (AN-201). Small-cell lung carcinomas (SCLCs) are...
Autores principales: | Kiaris, H, Schally, A V, Nagy, A, Sun, B, Armatis, P, Szepeshazi, K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362957/ https://www.ncbi.nlm.nih.gov/pubmed/10576652 http://dx.doi.org/10.1038/sj.bjc.6690794 |
Ejemplares similares
-
Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
por: Pinski, J., et al.
Publicado: (1994) -
Inhibition of growth of OV-1063 human epithelial ovarian cancers and c- jun and c- fos oncogene expression by bombesin antagonists
por: Chatzistamou, I, et al.
Publicado: (2000) -
Effective treatment of experimental U-87MG human glioblastoma in nude mice with a targeted cytotoxic bombesin analogue, AN-215
por: Szereday, Z, et al.
Publicado: (2002) -
Positron Emission Tomography Imaging of the Gastrin-Releasing
Peptide Receptor with a Novel Bombesin Analogue
por: Lau, Joseph, et al.
Publicado: (2019) -
Bombesin antagonists inhibit proangiogenic factors in human experimental breast cancers
por: Bajo, A M, et al.
Publicado: (2004)